A successful commercial leader, Annaswamy Vaidheesh, president of OPPI, VP South Asia and managing director at GSK India, talks about the tremendous work that the local affiliate is doing in the country in making innovative products available to patients and their recent GBP 100 million investment in manufacturing.
Can you give us an overview of the scope of the Indian operations of GSK in terms key therapeutic areas and key growth drivers?
"We want to be the number one among multinational companies in India as well as the most admired company in the country while continuing serving the Indian population – as simple as that."
